Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Magdy Shenouda"'
Autor:
Anthony E. Pusateri, Magdy Shenouda, Marcus E. Carr, Don A. Gabriel, Naum Khutoryansky, Brett E. Skolnick
Publikováno v:
Anesthesia and analgesia. 113(4)
BACKGROUND: Clopidogrel (Plavix) therapy, although effective for minimizing risk of thrombotic events, is also associated with potential bleeding risk. Recombinant activated FVII (rFVIIa, NovoSeven) induces hemostasis in hemophilia patients with inhi
Autor:
Bruno Imbimbo, Donna Mackintosh, Tara Aponte, Enrico Frigerio, Massimo Breda, Mercedes Fernandez, Luciana Giardino, Laura Calzà, Dottie Norris, Karen Wagner, Magdy Shenouda
Publikováno v:
Alzheimer's & Dementia. 7
Autor:
Albena Patroneva, Penny Fatato Rn, Qin Jiang, Jennifer A. Isler, Ronald Pedersen, Magdy Shenouda, Jeffrey Paul, Saeeduddin Ahmed, Alice I. Nichols
Publikováno v:
Journal of clinical pharmacology. 49(2)
The potential for cytochrome P450 (CYP) 2D6 substrates to interact with desvenlafaxine (administered as desvenlafaxine succinate) and paroxetine was evaluated. In an open-label, crossover study, 20 healthy volunteers (aged 21-50) were randomized to 2
Autor:
Mark Allison, Daniel E. Salazar, Magdy Shenouda, Shashank Rohatagi, Robert J. Noveck, Stephen Haworth, Igor Rubets, Mohinder S. Bathala, Reinilde Heyrman, James Lee
Publikováno v:
Journal of clinical pharmacology. 48(11)
The pharmacokinetics of amlodipine and olmesartan in healthy volunteers after coadministration of amlodipine besylate and olmesartan medoxomil concomitantly as separate dosage forms and together in a fixed-dose combination tablet were characterized i
Publikováno v:
American journal of nephrology. 25(4)
Background: Currently available intravenous iron preparations are not ideal, either because of safety concerns or dose limitations. We investigated the safety and pharmacokinetics of ferumoxytol, a new iron replacement therapy, in normal subjects and
Autor:
Christine Reynolds, Magdy Shenouda, Christiane Rordorf, Wayne K. Langholff, Slavica Milosavljev, Graham Scott
Publikováno v:
Clinical pharmacokinetics. 43(5)
To evaluate the effects of multiple doses of omeprazole and of a single dose of an aluminium hydroxide/magnesium hydroxide (Al/Mg) antacid on the single-dose plasma pharmacokinetics of lumiracoxib.Open-label, randomised, three-period, crossover study